Prognostic impact of vascular disease in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation

Ameenathul M Fawzy1, Arnaud Bisson2, Gregory Y H Lip3

  • 1Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.

PubMed

Insights

Patients with atrial fibrillation (AF) and vascular disease face increased risks of all-cause mortality, stroke, and major bleeding. Careful management of these conditions is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Epidemiology

Background:

  • Vascular disease, including peripheral artery disease, coronary artery disease, and aortic disease, is linked to higher risks of atrial fibrillation (AF) and ischemic stroke (IS) in AF patients.
  • Understanding the impact of vascular disease on AF prognosis is essential for clinical management.

Purpose of the Study:

  • To investigate the effect of co-existing vascular disease on the prognosis of patients diagnosed with atrial fibrillation (AF).

Main Methods:

  • A retrospective analysis included 8962 AF patients, categorized into groups with and without vascular disease.
  • Outcomes assessed included a composite of death, stroke, thromboembolic events, all-cause mortality (ACM), stroke or systemic embolism (SSE), IS, hemorrhagic stroke, and major bleeding.

Main Results:

  • Patients with vascular disease showed a higher univariate risk for ACM, SSE, IS, and major bleeding compared to those without.
  • Multivariate analysis, after adjusting for CHA2DS2-VASc score and antithrombotic use, confirmed significantly increased risks of ACM, SSE, and major bleeding in AF patients with vascular disease.
  • The increased risk for IS was no longer significant in multivariate analysis, and a non-significant lower risk for hemorrhagic stroke was observed in patients with vascular disease.

Conclusions:

  • Atrial fibrillation patients with vascular disease face elevated risks of all-cause mortality, stroke or systemic embolism, and major bleeding.
  • This patient group requires comprehensive management strategies focusing on risk factor control and tailored treatment.
  • Further research is needed to fully elucidate the relationship between vascular disease and AF prognosis.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
464
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
415
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
477
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
586